IMR Press / EJGO / Volume 32 / Issue 6 / pii/1630981966565-1686308076

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma
Show Less
1 Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Aichi
2 Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo (Japan)
Eur. J. Gynaecol. Oncol. 2011, 32(6), 611–614;
Published: 10 December 2011

Purpose: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasminogen activator inhibitor-1 (PAI-1) expression in patients with OCCA and attempted to assess its biological significance. Methods: Fifty-seven patients with OCCA were enrolled. We used formalin-fixed, paraffin-embedded sections of the primary tumor obtained at the first operation to investigate the immunohistochemical expression of PAI-1 and the association of PAI-1 expression with various clinicopathologic factors. Results: The 57 patients were classified into a high PAI-1 expression group and a low expression group. Comparison between the two groups revealed that the percentage of patients with concomitant endometriosis was significantly larger in the high expression group, while the percentage of Stage I patients with positive peritoneal cytology was significantly larger in the low expression group. Comparison of cumulative 5-year survival rates showed that the high expression group had a better prognosis than the low expression group. Conclusion: These data suggest an association between concomitant endometriosis and increased expression of PAI-1 in OCCA. The data also suggest that PAI-1 expression influences both peritoneal dissemination of early OCCA and the prognosis.
Ovarian cancer
Clear cell adenocarcinoma
Plasminogen activator inhibitor-1
Peritoneal cytology
Back to top